Emergent initiates $50m expansion, expects to hire 60

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Neznam)
(Image: Getty/Neznam)
Emergent BioSolutions has initiated a $50m multi-year expansion at the company’s Baltimore, MD-based fill/finish facility.

The expansion – expected to be completed in 2021 – will see the addition of a new isolator enclosed fill line.

Groninger & Co. will install the FlexPro 50 filler with isolator technology and an integrated Christ lyophilizer at the company's facility in Baltimore​. The line will have the capability to fill vials, syringes, and cartridges.

Additionally, Emergent BioSolutions will be adding a second autoclave to increase its sterilization capacity and provide manufacturing redundancy.

The addition also will provide new cold storage space to support 2-8⁰c and -20⁰c requirements, new stability chambers, new media fill incubators, and additional warehousing and office space, according to the company.

An additional 60 new jobs are expected to be created in the next three years, according to the contract development and manufacturing organization​ (CDMO).

BJ Hull, vice president, general manager and site head at the Camden facility, said in a press release: “This $50 million investment further demonstrates our commitment to meeting and exceeding the expectations of our customers as well as to stimulating economic growth and creating jobs in Baltimore.”

Related news

Show more

Related products

show more

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Related suppliers

Follow us


View more